Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
Trial details
- Registry ID
- NCT06058013
- Drugs studied
- NMRA-335140
TrialRedline tracks 6 clinical trials sponsored by Neumora Therapeutics, Inc.: 4 Phase 3, 2 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06058013 | NMRA-335140 | Completed | 2026-05-06Actual |
| Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderNCT06058039 | NMRA-335140 | Completed | 2026-05-04Actual |
| Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderNCT06029426 | NMRA-335140 | Completed | 2024-12-03Actual |
| Study to Assess the Safety and Effectiveness of NMRA-335140-501NCT06029439 | NMRA-335140 | Terminated | 2026-08-17Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.NCT06429722 | NMRA-335140 80 mg | Completed | 2025-04-09Actual |
| Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs PlaceboNCT04221230 | NMRA-335140 | Completed | 2022-04-08Actual |
Names as written in the registry records.
NCT06029439 · Neumora Therapeutics, Inc.
Before: Estimated. After: Actual.
Before: 1000 participants (planned). After: 904 participants (actual).
Before: Estimated. After: Actual.
Before: Jun 2027. After: 17 Aug 2026.
Before: Active not recruiting. After: Terminated.
NCT06058013 · Neumora Therapeutics, Inc.
Before: Estimated. After: Actual.
Before: 332 participants (planned). After: 430 participants (actual).
Before: Estimated. After: Actual.
Before: May 2026. After: 6 May 2026.
Before: Active not recruiting. After: Completed.
NCT06058039 · Neumora Therapeutics, Inc.
Before: Estimated. After: Actual.
Before: 332 participants (planned). After: 422 participants (actual).
Before: Estimated. After: Actual.
Before: May 2026. After: 4 May 2026.
Before: Active not recruiting. After: Completed.
NCT06029439 · Neumora Therapeutics, Inc.
Before: Recruiting. After: Active not recruiting.
NCT06058013 · Neumora Therapeutics, Inc.
Before: Recruiting. After: Active not recruiting.
NCT06058039 · Neumora Therapeutics, Inc.
Before: Feb 2026. After: May 2026.
Before: Recruiting. After: Active not recruiting.